Profile picture

Doctor Sina Fathieh

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
Follow
Logo ESC

Contributor content

Plasma lysozyme as surrogate biomarker for detection of coronary artery disease in patients without Standard Modifiable Cardiovascular Risk Factors (SMuRFless)
Presentation
Plasma lysozyme as surrogate biomarker for detection of coronary artery disease in patients without Standard Modifiable Cardiovascular Risk Factors (SMuRFless)
Read more
Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality
Presentation
Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality
Read more
Examining the predictive value of plasma lysozyme for future all-cause mortality
Presentation
Examining the predictive value of plasma lysozyme for future all-cause mortality
Read more
Predicting ECGs masquerading AS STEMI with machine learning
Presentation
Predicting ECGs masquerading AS STEMI with machine learning
Read more
Reduction in acute coronary events without excess out of hospital cardiac arrest during the COVID-19 lockdown of 2020 in new South Wales, Australia
Presentation
Reduction in acute coronary events without excess out of hospital cardiac arrest during the COVID-19 lockdown of 2020 in new South Wales, Australia
Read more
Acute exposure to PM2.5 promotes arterial stiffening by down-regulating serine and trans-4-hydroxyproline dependent pathways - results from an Asutralian cohort metabolomic study
Presentation
Acute exposure to PM2.5 promotes arterial stiffening by down-regulating serine and trans-4-hydroxyproline dependent pathways - results from an Asutralian cohort metabolomic study
Read more

ESC 365 is supported by

novartis Explore sponsored resources